Lipoxin A4 inhibits lipopolysaccharide-induced production of inflammatory cytokines in keratinocytes by up-regulating SOCS2 and down-regulating TRAF6

Abstract

Liopxin A4 (LXA4) is considered to be a crucial modulator in the inflammatory responses. In the present study, we aimed to study the effect of LXA4 on the inflammatory cytokines production induced by lipopolysaccharide (LPS) and the possible mechanism in normal human epidermal keratinocytes (NHEKs). NHEKs were isolated and cultured. The expression of toll-like receptor 4 (TLR4), LXA4 receptor (ALXR) and aryl hydrocarbon receptor (AhR) in NHEKs was detected by reverse transcription polymerase chain reaction (RT-PCR). The mRNA and protein levels of tumor necrosis factor-alpha (TNF-α) and interleukin-1β (IL-1β) were determined in NHEKs stimulated by LPS (10 μg/mL) with or without preincubation with LXA4 (100 nmol/L) for 30 min by real-time quantitative PCR (real-time qPCR) and enzyme-linked immunosorbent assay (ELISA), respectively. The expression levels of tumor necrosis factor receptor-associated factor 6 (TRAF6) and suppressors of cytokine signaling 2 (SOCS2) mRNAs and proteins, and nuclear translocation of NF-kB-p65 were measured by real-time qPCR and Western blotting, respectively. The results showed that NHEKs expressed TLR4, ALXR and AhR. LXA4 significantly inhibited the mRNA and protein expression levels of TNF-α, IL-1β and TRAF6 induced by LPS in NHEKs, and LXA4 obviously increased the expression of SOCS2 at mRNA and protein levels. The nuclear NF-kB-p65 protein expression induced by LPS was inhibited after preincubation with LXA4 in NHEKs. It was concluded that LXA4 inhibits the LPS-induced production of TNF-α and IL-1β in NHEKs by up-regulating SOCS2 and down-regulating TRAF6.

Keywords

keratinocyte / inflammatory cytokine / LXA4 / SOCS2 / TRAF6 / NF-κB

References

[1] SerhanCN, ChiangN, Van DykeTE. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol, 2008, 8(5): 349-361 PMCID: 2744593 PMID: 18437155

[2] FukunagaK. Cyclooxygenase 2 derived lipid mediators play a pivotal role in resolution of acute lung injury. Nihon Kokyuki Gakkai Zasshi, 2008, 46(2): 156-164 PMID: 18318262

[3] MerchedAJ, KoK, GotlingerKH, et al. . Atherosclerosis: evidence for impairment of resolution of vascular inflammation governed by specific lipid mediators. FASEB J, 2008, 22(10): 3595-3606 PMCID: 2537438 PMID: 18559988

[4] WangJ, HuangY, ZhouJ, et al. . Effect of lipoxin A(4) on IL-1beta production of monocytes and its possible mechanism in severe preeclampsia. J Huazhong Univ Sci Technolog Med Sci, 2010, 30(6): 767-770 PMID: 21181369

[5] ShimizuS, OgawaT, SenoS, et al. . Pro-resolution mediator lipoxin A4 and its receptor in upper airway inflammation. Ann Otol Rhinol Laryngol, 2013, 122(11): 683-689 PMID: 24358628

[6] WuSH, LuC, DongL, et al. . Lipoxin A4 inhibits TNF-alpha-induced production of interleukins and proliferation of rat mesangial cells. Kidney Int, 2005, 68(1): 35-46 PMID: 15954894

[7] Sodin-SemrlS, TaddeoB, TsengD, et al. . Lipoxin A4 inhibits IL-1 beta-induced IL-6, IL-8, and matrix metalloproteinase-3 production in human synovial fibroblasts and enhances synthesis of tissue inhibitors of metalloproteinases. J Immunol, 2000, 164(5): 2660-2666 PMID: 10679106

[8] MachadoFS, JohndrowJE, EsperL, et al. . Aliberti, J., Anti-inflammatory actions of lipoxin A4 and aspirin-triggered lipoxin are SOCS-2 dependent. Nat Med, 2006, 12(3): 330-334 PMID: 16415877

[9] FioreS, MaddoxJF, PerezHD, et al. . Identification of a human cDNA encoding a functional high affinity lipoxin A4 receptor. J Exp Med, 1994, 180(1): 253-260 PMID: 8006586

[10] LuoCL, LiQQ, ChenXP, et al. . Lipoxin A4 attenuates brain damage and downregulates the production of pro-inflammatory cytokines and phosphorylated mitogen-activated protein kinases in a mouse model of traumatic brain injury. Brain Res, 2013, 1502: 1-10 PMID: 23370001

[11] FierroIM, SerhanCN. Mechanisms in anti-inflammation and resolution: the role of lipoxins and aspirin-triggered lipoxins. Braz J Med Biol Res, 2001, 34(5): 555-566 PMID: 11323741

[12] AnselJ, PerryP, BrownJ, et al. . Cytokine modulation of keratinocyte cytokines. J Invest Dermatol, 1990, 94(6–l): 101S-107S PMID: 2161884

[13] KockA, SchwarzT, KirnbauerR, et al. . Human keratinocytes are a source for tumor necrosis factor alpha: evidence for synthesis and release upon stimulation with endotoxin or ultraviolet light. J Exp Med, 1990, 172(6): 1609-1614 PMID: 2258696

[14] NeunerP, UrbanskiA, TrautingerF, et al. . Increased IL-6 production by monocytes and keratinocytes in patients with psoriasis. J Invest Dermatol, 1991, 97(1): 27-33 PMID: 2056189

[15] HeQ, ChenHX, LiW, et al. . IL-36 cytokine expression and its relationship with p38 MAPK and NF-κB pathways in psoriasis vulgaris skin lesions. J Huazhong Univ Sci Technolog Med Sci, 2013, 33(4): 594-599 PMID: 23904383

[16] WuSH, WuXH, LuC, et al. . Lipoxin A4 inhibits proliferation of human lung fibroblasts induced by connective tissue growth factor. Am J Respir Cell Mol Biol, 2006, 34(1): 65-72 PMID: 16141446

[17] McBerryC, GonzalezRM, ShryockN, et al. . SOCS2-induced proteasome-dependent TRAF6 degradation: a common anti-inflammatory pathway for control of innate immune responses. PLoS One, 2012, 7(6): e38384 PMCID: 3367914 PMID: 22693634

[18] LebreMC, van der AarAM, van BaarsenL, et al. . Human keratinocytes express functional Toll-like receptor 3, 4, 5, and 9. J Invest Dermatol, 2007, 127(2): 331-341 PMID: 17068485

[19] TomokiyoA, MaedaH, FujiiS, et al. . Alternation of extracellular matrix remodeling and apoptosis by activation of the aryl hydrocarbon receptor pathway in human periodontal ligament cells. J Cell Biochem, 2012, 113(10): 3093-3103 PMID: 22581694

[20] WangSS, KamphuisW, HuitingaI, et al. . Gene expression analysis in the human hypothalamus in depression by laser microdissection and real-time PCR: the presence of multiple receptor imbalances. Mol Psychiatry, 2008, 13(8): 786-799 PMID: 18427561

[21] BoeufP, Vigan-WomasI, JublotD, et al. . CyProQuant-PCR: a real time RT-PCR technique for profiling human cytokines, based on external RNA standards, readily automatable for clinical use. BMC Immunol, 2005, 6: 5 PMCID: 555737 PMID: 15748278

[22] HuangF, KaoCY, WachiS, et al. . Requirement for both JAK-mediated PI3K signaling and ACT1/TRAF6/TAK1-dependent NF-kappaB activation by IL-17A in enhancing cytokine expression in human airway epithelial cells. J Immunol, 2007, 179(10): 6504-6513 PMID: 17982039

[23] LeungKC, DoyleN, BallesterosM, et al. . Estrogen inhibits GH signaling by suppressing GH-induced JAK2 phosphorylation, an effect mediated by SOCS-2. Proc Natl Acad Sci USA, 2003, 100(3): 1016-1021 PMCID: 298718 PMID: 12552091

[24] MadernaP, GodsonC. Lipoxins: resolutionary road. Br J Pharmacol, 2009, 158(4): 947-959 PMCID: 2785518 PMID: 19785661

[25] HuF, LiuXX, WangX, et al. . Lipoxin A4 inhibits proliferation and inflammatory cytokine/chemokine production of human epidermal keratinocytes associated with the ERK1/2 and NF-kB pathways. J Dermatol Sci, 2015, 78(3): 181-188 PMID: 25847211

[26] BegonE1, MichelL, FlageulB, et al. . Expression, subcellular localization and cytokinic modulation of Toll-like receptors (TLRs) in normal human keratinocytes: TLR2 up-regulation in psoriatic skin. Eur J Dermatol, 2007, 17(6): 497-506 PMID: 17951129

[27] SaracenoR1, SchipaniC, MazzottaA, et al. . Effect of anti-tumor necrosis factor-a therapies on body mass index in patients with psoriasis. Pharmacol Res, 2008, 57(4): 290-295 PMID: 18400510

[28] DinarelloCA, CannonJG, WolffSM, et al. . Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1. J Exp Med, 1986, 163(6): 1433-1450 PMID: 3486936

[29] MatsushimaK, OppenheimJJ. Interleukin 8 and MCAF: novel inflammatory cytokines inducible by IL 1 and TNF. Cytokine, 1989, 1(1): 2-13 PMID: 2491503

[30] ZepterK, HaffnerA, SoohooLF, et al. . Induction of biologically active IL-1 beta-converting enzyme and mature IL-1 beta in human keratinocytes by inflammatory and immunologic stimuli. J Immunol, 1997, 159(12): 6203-6208 PMID: 9550423

[31] SutterwalaFS, OguraY, SzczepanikM, et al. . Critical role for NALP3/CIAS1/Cryopyrin in innate and adaptive immunity through its regulation of caspase-1. Immunity, 2006, 24(3): 317-327 PMID: 16546100

[32] KobayashiT, WalshMC, ChoiY. The role of TRAF6 in signal transduction and the immune response. Microbes Infect, 2004, 6(14): 1333-1338 PMID: 15555541

[33] ChenF, HeS, QiuR, et al. . Influence of silencing TRAF6 with shRNA on LPS/TLR4 signaling in vitro. J Huazhong Univ Sci Technolog Med Sci, 2010, 30(3): 278-284 PMID: 20556568

[34] JakusPB, KalmanN, AntusC, et al. . TRAF6 is functional in inhibition of TLR4-mediated NF-kappaB activation by resveratrol. J Nutr Biochem, 2013, 24(5): 819-823 PMID: 22925919

[35] LiewFY, XuD, BrintEK, et al. . Negative regulation of toll-like receptor-mediated immune responses. Nat Rev Immunol, 2005, 5(6): 446-458 PMID: 15928677

[36] PosseltG, SchwarzH, DuschlA, et al. . Suppressor of cytokine signaling 2 is a feedback inhibitor of TLR-induced activation in human monocyte-derived dendritic cells. J Immunol, 2011, 187(6): 2875-2884 PMID: 21844389

[37] TegederI, NiederbergerE, IsrarE, et al. . Inhibition of NF-kappaB and AP-1 activation by R- and S-flurbiprofen. FASEB J, 2001, 15(1): 2-4 PMID: 11099482